{
    "eid": "2-s2.0-85062170888",
    "title": "Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline from a 3-Year Follow-up Clinical Study",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "hepatitis B virus",
        "kidney transplantation",
        "vaccination"
    ],
    "authors": [
        "Wiwat Chancharoenthana",
        "Asada Leelahavanichkul",
        "Suwasin Udomkarnjananun",
        "Salin Wattanatorn",
        "Yingyos Avihingsanon",
        "Kearkiat Praditpornsilpa",
        "Kriang Tungsanga",
        "Somchai Eiam-Ong",
        "Natavudh Townamchai"
    ],
    "citedby-count": 5,
    "ref-count": 38,
    "ref-list": [
        "Viral hepatitis in solid organ transplantation other than liver",
        "The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection",
        "Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C",
        "HBV reactivation after kidney transplantation",
        "Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection",
        "Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: Report on three cases and review of the literature",
        "Hepatitis B virus reactivation after renal transplantation: Report of two cases",
        "Immune responses to hepatitis B immunization 10-18 years after primary vaccination: A population-based cohort study",
        "Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population",
        "A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults",
        "KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease",
        "What level of hepatitis B antibody is protective?",
        "Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination",
        "Humoral immunity after kidney transplantation: Impact of two randomized immunosuppressive protocols",
        "KDIGO clinical practice guideline for the care of kidney transplant recipients",
        "The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome",
        "Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors",
        "Kidney transplantation from hepatitis B surface antigen positive donors into hepatitis B surface antibody positive recipients: A prospective nonrandomized controlled study from a single center",
        "Successful outcome of kidney transplantation from a HBV-DNA positive donor into recipients with cleared HBVinfection using a pre-emptive therapy approach",
        "Hepatitis B surface antigen positivity is not a contraindication for living kidney donation",
        "Successful kidney transplantation from a hepatitis B surface antigen-positive donor to an antigen-negative recipient using a novel vaccination regimen",
        "Hepatitis transmission risk in kidney transplantation (the HINT study): A cross-sectional survey of transplant clinicians in Australia and New Zealand",
        "The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: A retrospective, propensity scorematched study",
        "False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States",
        "Hepatitis B virus transcription and replication",
        "Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy",
        "Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay",
        "Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay",
        "Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B",
        "Incidence of hepatitis B viral reactivation after kidney transplantation with low-dose rituximab administration",
        "Chronic hepatitis B: Update 2009",
        "Duration of humoral immunity to common viral and vaccine antigens",
        "Benefits and risks of nucleoside analog therapy for hepatitis B",
        "Solid organ transplantation from hepatitis B virus-positive donors: Consensus guidelines for recipient management",
        "Statements from the Taormina expert meeting on occult hepatitis B virus infection",
        "Cost-effectiveness of hepatitis B vaccination using HEPLISAV\u2122 in selected adult populations compared to Engerix-BR vaccine",
        "Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age",
        "Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Development of New Faculty Staff Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}